Immunoassay reveals why some people don't get sick often
AD |
Science and Technology Daily, Beijing, June 14 (Reporter Zhang Mengran) Why can some people stay healthy all their lives? A study published on the 13th in Nature Communications suggests that immune resilience, the ability to maintain or restore immune function, may be related to the ability to respond to infectious and inflammatory diseases. This is a conclusion drawn from investigating the background of multiple infectious and inflammatory diseases, which may improve people's understanding of immunity and health
Science and Technology Daily, Beijing, June 14 (Reporter Zhang Mengran) Why can some people stay healthy all their lives? A study published on the 13th in Nature Communications suggests that immune resilience, the ability to maintain or restore immune function, may be related to the ability to respond to infectious and inflammatory diseases. This is a conclusion drawn from investigating the background of multiple infectious and inflammatory diseases, which may improve people's understanding of immunity and health.
Why some people have longer lifespans and are less susceptible to infectious and inflammatory diseases is a question that has not been fully understood. Infections and inflammatory diseases lead to changes in the immune system, and the magnitude and quality of disease response may vary from person to person. Some people believe that the optimal response to infectious and inflammatory diseases is related to life expectancy, but further research is needed.
The San Antonio Health Science Center at the University of Texas in the United States investigated a series of data based on human and animal studies to estimate immune resilience in various scenarios. They investigated over 48500 individuals and various animal models and found that some individuals were able to maintain immune recovery during exposure to different infectious and inflammatory diseases, as well as during the aging process. The existence of immune resilience in infectious or inflammatory diseases is related to life extension and favorable health outcomes of a series of diseases involved in the study, including AIDS, symptomatic influenza infection, COVID-19 infection, sepsis and recurrent skin cancer. This study also suggests that optimal immune resilience can be detected at all ages, may be more common in women, and may be associated with favorable immune dependent health outcomes.
Researchers believe that immune resilience can be used for monitoring in the future and may provide information for prognosis and management of health outcomes, including longevity and infection response. However, further research is needed to determine the effectiveness and use of measuring immune resilience for diagnosis, prediction and management of inflammatory and infectious diseases.
Disclaimer: The content of this article is sourced from the internet. The copyright of the text, images, and other materials belongs to the original author. The platform reprints the materials for the purpose of conveying more information. The content of the article is for reference and learning only, and should not be used for commercial purposes. If it infringes on your legitimate rights and interests, please contact us promptly and we will handle it as soon as possible! We respect copyright and are committed to protecting it. Thank you for sharing.(Email:[email protected])
Mobile advertising space rental |
Tag: Immunoassay reveals why some people don get sick often
Accenture plans to invest 3 billion dollars in AI field within three years
NextThe two departments will organize pilot cities for Digital transformation of SMEs
Guess you like
-
Liaoning Province and Baidu Sign Strategic Cooperation Framework Agreement to Jointly Promote AI Industry DevelopmentDetail
2024-12-20 19:36:38 1
-
Wanxun Technology Secures Nearly RMB 200 Million in Funding to Lead Global Soft Robotics Innovation, Set to Showcase Breakthroughs at CES 2025Detail
2024-12-20 15:54:19 1
-
Huolala's 2025 Spring Festival Freight Festival: Supporting Spring Festival Travel, Offering New Year Benefits to Users and DriversDetail
2024-12-20 13:38:20 1
-
The Third Meeting of the Third Council of the International New Energy Solutions Platform (INES): Charting a Blueprint for a "Dual Carbon" FutureDetail
2024-12-19 17:03:07 1
-
WeChat's Official Account Launches "Author Read Aloud Voice" Feature for Personalized Article ListeningDetail
2024-12-18 17:19:57 1
-
The 12th China University Students' Polymer Materials Innovation and Entrepreneurship Competition Finals Grand Opening in Guangrao CountyDetail
2024-12-18 16:04:28 1
-
Tracing the Ancient Shu Road, Winds of the Three Kingdoms: Global Influencer Shu Road Journey LaunchesDetail
2024-12-18 15:23:35 1
-
Seres: A Pioneer in ESG Practices, Driving Sustainable Development of China's New Energy Vehicle IndustryDetail
2024-12-17 16:20:26 1
- Detail
-
My Health, My Guard: Huawei WATCH D2 Aids Precise Blood Pressure Management in the Winter Health BattleDetail
2024-12-17 09:36:15 1
-
Investigation into the Chaos of Airline Seat Selection: Paid Seat Selection, Seat Locking Mechanisms, and Consumer Rights ProtectionDetail
2024-12-15 16:45:48 1
-
Japanese Scientists Grow Human Organs in Pigs: A Balancing Act of Breakthrough and EthicsDetail
2024-12-14 19:48:50 1
-
Pang Donglai and Sam's Club: Two Paths to Transformation in China's Retail IndustryDetail
2024-12-14 17:57:03 1
-
In-Depth Analysis of China's Precision Reducer Industry: Technological Innovation and Market CompetitionDetail
2024-12-14 16:04:26 1
-
Alibaba's "TAO" App Launches in Japan, Targeting High-Quality Service and Convenient LogisticsDetail
2024-12-13 13:22:23 1
-
In-depth Analysis of China's Cross-border E-commerce Industry Chain: Opportunities and Challenges CoexistDetail
2024-12-13 11:37:17 1
-
Sweet Potato Robotics: How a Unified Software and Hardware Computing Platform Accelerates Robotics Industry DevelopmentDetail
2024-12-13 06:36:34 1
- Detail
-
Yang Liwei: From China's First Taikonaut to a Cornerstone of the Space ProgramDetail
2024-12-12 03:27:26 1
- Detail